Share the Savings with Seniors Act
Sponsored By: Senator John Cornyn
Introduced
Summary
Would tie Medicare Part D cost-sharing for chronic care drugs to the drug's net price to lower patient costs and change coinsurance rules. The proposal would apply to chronic care drugs and start for plan years beginning January 1, 2027.
Show full summary
- People on Medicare who take chronic care drugs would face lower upfront charges because plans must cap cost-sharing below the annual deductible at each drug's net price and use coinsurance tied to net price between the deductible and the out-of-pocket threshold. The bill's drug list follows United States Pharmacopeia categories like non‑insulin blood glucose regulators, inhaled corticosteroids, bronchodilators, anticoagulants, and cardiovascular agents.
- Low-income Medicare enrollees would have their copayments for covered chronic drugs limited to the applicable cost-sharing in the prescription drug plan or Medicare Advantage prescription drug plan where they are enrolled beginning in 2027.
- Plans, pharmacy benefit managers, and manufacturers would calculate a defined “net price” that subtracts manufacturer price concessions when setting patient cost-sharing. The bill would also direct the Secretary to implement the changes initially through interim final regulations.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
New Medicare drug savings for seniors
If enacted, this bill would set new cost-sharing rules for many Medicare Part D "chronic care drugs." The changes would apply to plan years beginning on January 1, 2027. For drug costs below the Part D deductible, your cost-sharing could not be more than the drug's net price. The bill defines "net price" as the negotiated price minus manufacturer discounts that are not already included in the negotiated price. Between the deductible and the out-of-pocket threshold, coinsurance must be a percent of the drug's net price unless your plan uses a flat copayment not tied to price. If you get the Part D low-income subsidy, your copayment for these drugs could not be more than your plan's usual charge. If enacted, the bill would also direct HHS to use interim final rules so these changes can start right away.
Sponsors & CoSponsors
Sponsor
John Cornyn
TX • R
Cosponsors
Jacky Rosen
NV • D
Sponsored 9/11/2025
Thomas Tillis
NC • R
Sponsored 9/11/2025
Peter Welch
VT • D
Sponsored 9/11/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in